1. Home
  2. PFE vs SNPS Comparison

PFE vs SNPS Comparison

Compare PFE & SNPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pfizer Inc.

PFE

Pfizer Inc.

HOLD

Current Price

$24.28

Market Cap

147.6B

Sector

Health Care

ML Signal

HOLD

Logo Synopsys Inc.

SNPS

Synopsys Inc.

HOLD

Current Price

$454.12

Market Cap

87.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFE
SNPS
Founded
1849
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
147.6B
87.2B
IPO Year
2013
1994

Fundamental Metrics

Financial Performance
Metric
PFE
SNPS
Price
$24.28
$454.12
Analyst Decision
Buy
Buy
Analyst Count
14
14
Target Price
$29.29
$540.71
AVG Volume (30 Days)
32.6M
2.0M
Earning Date
05-05-2026
05-27-2026
Dividend Yield
6.55%
N/A
EPS Growth
N/A
N/A
EPS
0.47
0.43
Revenue
$62,579,000,000.00
$5,081,542,000.00
Revenue This Year
N/A
$39.22
Revenue Next Year
N/A
$10.73
P/E Ratio
$50.29
$1,058.19
Revenue Growth
N/A
20.87
52 Week Low
$23.11
$376.18
52 Week High
$28.75
$651.65

Technical Indicators

Market Signals
Indicator
PFE
SNPS
Relative Strength Index (RSI) 33.34 42.83
Support Level $24.02 $443.11
Resistance Level $26.42 $488.81
Average True Range (ATR) 0.56 18.42
MACD -0.20 -0.78
Stochastic Oscillator 17.25 36.12

Price Performance

Historical Comparison
PFE
SNPS

About PFE Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

About SNPS Synopsys Inc.

Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Share on Social Networks: